Sherman Simon, Shats Oleg, Fleissner Elizabeth, Bascom George, Yiee Kevin, Copur Mehmet, Crow Kate, Rooney James, Mateen Zubeena, Ketcham Marsha A, Feng Jianmin, Sherman Alexander, Gleason Michael, Kinarsky Leo, Silva-Lopez Edibaldo, Edney James, Reed Elizabeth, Berger Ann, Cowan Kenneth
Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE, USA.
Cancer Inform. 2011;10:217-26. doi: 10.4137/CIN.S7845. Epub 2011 Aug 31.
The Breast Cancer Collaborative Registry (BCCR) is a multicenter web-based system that efficiently collects and manages a variety of data on breast cancer (BC) patients and BC survivors. This registry is designed as a multi-tier web application that utilizes Java Servlet/JSP technology and has an Oracle 11g database as a back-end. The BCCR questionnaire has accommodated standards accepted in breast cancer research and healthcare. By harmonizing the controlled vocabulary with the NCI Thesaurus (NCIt) or Systematized Nomenclature of Medicine-Clinical Terms (SNOMED-CT), the BCCR provides a standardized approach to data collection and reporting. The BCCR has been recently certified by the National Cancer Institute's Center for Biomedical Informatics and Information Technology (NCI CBIIT) as a cancer Biomedical Informatics Grid (caBIG(®)) Bronze Compatible product.The BCCR is aimed at facilitating rapid and uniform collection of critical information and biological samples to be used in developing diagnostic, prevention, treatment, and survivorship strategies against breast cancer. Currently, seven cancer institutions are participating in the BCCR that contains data on almost 900 subjects (BC patients and survivors, as well as individuals at high risk of getting BC).
乳腺癌协作登记处(BCCR)是一个基于网络的多中心系统,可有效收集和管理有关乳腺癌(BC)患者及乳腺癌幸存者的各类数据。该登记处设计为一个多层网络应用程序,采用Java Servlet/JSP技术,并以Oracle 11g数据库作为后端。BCCR问卷符合乳腺癌研究和医疗保健领域公认的标准。通过将控制词汇与美国国立癌症研究所术语表(NCIt)或医学临床术语系统命名法(SNOMED-CT)进行协调,BCCR提供了一种标准化的数据收集和报告方法。BCCR最近已获得美国国立癌症研究所生物医学信息学和信息技术中心(NCI CBIIT)认证,成为癌症生物医学信息网格(caBIG(®))青铜兼容产品。BCCR旨在促进快速、统一地收集关键信息和生物样本,用于制定针对乳腺癌的诊断、预防、治疗及生存策略。目前,七家癌症机构参与了BCCR,该登记处包含近900名受试者(乳腺癌患者和幸存者,以及乳腺癌高危个体)的数据。